NEW YORK (GenomeWeb News) – Thermo Fisher Scientific has priced its $1.3 billion offering of senior notes, the firm announced after the close of the market yesterday.

It is offering $500 million of 1.85 percent senior notes due 2018, and $800 million of 3.15 percent notes due 2023. The firm expects to close the offering on Aug. 22.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times reports that as China invests in science, it also is dealing with research fraud.

In PLOS this week: transcriptome study of a cold-tolerant plant, deep sequencing of clinical influenza A samples, and more.

The Atlantic writes that retrotransposons like BovB have proliferated in a number of genomes.

Researchers have sequenced the genome of a man who lived in China some 40,000 years ago, according to UPI.